China’s Ministry of Commerce has used the country's Anti-Monopoly Law to impose conditions on the proposed acquisition by Swiss pharmaceutical company Novartis AG of world-leading eye care company Alcon Inc. The decision has attracted particular scrutiny because of the unusual nature of the conditions imposed by the regulator, and the fact that it continues the Ministry's record of only restricting transactions between foreign multinationals.

Downloads –